Spero Oncology
2014
FOUNDED
M&A
STATUS
11-20
EMPLOYEES
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Operator of a clinical research organization (CRO) focused on development of oncology products. The company provides clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Decision/Risk Analysis
Other Industries
Pharmaceuticals
Laboratory Services (Healthcare)
Acquirer
Veristat
Primary Office
- Duart House 3 Finch Way
- Strathclyde Business Park
- Bellshill ML4 3PR
- Scotland
Spero Oncology Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Spero Oncology‘s full profile, request access.
Request full access to PitchBook